Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-103146

CEO and Chairman sold 2,444 shares at an average $14.01 ($34,237)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Pham Quang X · CEO and Chairman

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-24 Sale : show line 1 in the form 10b5-1 −1,129 $14.03 $15,840 197,404 D
2025-10-27 Sale : show line 2 in the form 10b5-1 −1,315 $13.99 $18,397 196,089 D
Open-market sales · 2,444 sh · avg $14.01 · $34,237
Loading xslF345X05/ownership.xml…